AI filing briefs · archive

8-K filings in February 2025, explained

1,027 material Form 8-K filings that 835 companies we cover made with the SEC in February 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

15 of 1,027 briefs match

newest first · times in ET
NTSTNETSTREIT Corp. Feb 24, 5:14 PM ET

NETSTREIT Q4 AFFO per share rises 3.2% to $0.32; net loss of $0.07 per share

Mixed earnings Written later 2.027.01

NETSTREIT reported fourth quarter 2024 results and initiated 2025 AFFO per share guidance of $1.27 to $1.30. AFFO per diluted share rose to $0.32 from $0.31, but the company posted a net loss of $0.07 per share after a $0.03 profit a year earlier, and full-year 2024 impairment provisions were $29.969 million versus $7.083 million in 2023.

  • Q4 2024 AFFO per diluted share was $0.32, up 3.2% from $0.31; Q4 net loss per diluted share was $(0.07) versus $0.03 in Q4 2023.
  • Q4 2024 investments totaled $195.1 million at a 7.4% cash yield, and dispositions totaled $59.3 million.
  • 2025 AFFO per share guidance is $1.27 to $1.30, with 2025 net investment activity expected at $75.0 million to $125.0 million.
  • Quarterly dividend declared at $0.21 per share, or $0.84 annualized, up $0.02 from the prior year, payable March 31, 2025.
Read the filing on SEC.gov ↗
BWXTBWX Technologies, Inc. Feb 24, 5:10 PM ET

BWXT Q4 revenue rises 3% to $746.3 million; non-GAAP EPS falls to $0.92

Mixed earnings Written later 2.02

BWX Technologies reported fourth quarter 2024 revenue of $746.3 million, up 3% from a year earlier, and GAAP diluted EPS of $0.77, up from $0.72. Non-GAAP diluted EPS fell 9% to $0.92, and GAAP operating income declined 25% to $92.3 million, so the quarter's headline measures moved in different directions. The company also initiated 2025 guidance calling for non-GAAP EPS of $3.40 to $3.55, compared with $3.33 for 2024.

  • Q4 2024 revenue $746.3 million, up 3%; GAAP diluted EPS $0.77 vs. $0.72; non-GAAP diluted EPS $0.92 vs. $1.01
  • Full year 2024 revenue $2.7 billion, up 8%; GAAP diluted EPS $3.07 vs. $2.68; non-GAAP diluted EPS $3.33 vs. $3.02
  • 2025 guidance: non-GAAP EPS $3.40-$3.55, adjusted EBITDA $550 million-$570 million, free cash flow $265 million-$285 million
  • Board declared a quarterly dividend of $0.25 per share, payable March 28, 2025
Read the filing on SEC.gov ↗

Air Products to exit three U.S. projects, booking pre-tax charge up to $3.1 billion

Mixed restructuring Written later 2.067.01

Air Products said a review by its newly elected Board and CEO led it to exit three U.S. projects. The company expects a pre-tax charge of no more than $3.1 billion in its fiscal 2025 second quarter, mainly for asset write-downs and contract terminations, with cash expenditures of no more than $800 million. The release says the charge will not affect fiscal 2025 adjusted earnings per share, but the size of the one-time charge and cash outlay is significant for shareholders.

  • Pre-tax charge not to exceed $3.1 billion in fiscal 2025 second quarter, primarily to write down assets and terminate contracts
  • Cash expenditures related to the charges estimated not to exceed $800 million
  • Exited projects: World Energy sustainable aviation fuel expansion in Paramount, California; Massena, New York green liquid hydrogen plant; carbon monoxide project in Texas
  • Company says the charge will not affect fiscal 2025 adjusted EPS; updates due in Form 10-Q for quarter ending March 31, 2025
Read the filing on SEC.gov ↗
AESIAtlas Energy Solutions Inc. Feb 24, 4:41 PM ET

Atlas Energy 2024 net income falls to $59.9 million; sales rise 72% to $1.1 billion

Mixed earnings Written later 2.027.01

Atlas Energy Solutions reported fourth-quarter and full-year 2024 results and said it completed its $220.0 million acquisition of Moser Energy Systems on February 24, 2025. Full-year sales rose to $1.1 billion, but net income fell to $59.9 million from $226.5 million in 2023, and fourth-quarter sales declined from the third quarter. The acquisition was funded in part by a $540.0 million term loan and a February 2025 share offering that raised $254.1 million net, and the Moser deal includes about 1.7 million shares of stock consideration.

  • Full-year 2024 sales rose $442.0 million, or 72.0%, to $1.1 billion, while net income was $59.9 million versus $226.5 million in 2023.
  • Fourth-quarter 2024 sales fell 10.9% sequentially to $271.3 million, while net income rose to $14.4 million from $3.9 million in the third quarter.
  • Fourth-quarter Adjusted EBITDA was $63.2 million, down 11.1% sequentially.
  • Moser acquisition was valued at $220.0 million, including $180.0 million cash; quarterly dividend raised to $0.25 per share, payable February 28, 2025.
Read the filing on SEC.gov ↗
KWRQUAKER CHEMICAL CORP Feb 24, 4:37 PM ET

Quaker Houghton Q4 sales fell 5% to $444.1 million; Q4 EPS $0.81 vs $1.12 a year earlier

Mixed earnings Written later 2.02

Quaker Houghton reported fourth quarter and full year 2024 results on February 24, 2025. Q4 net sales fell 5% to $444.1 million and diluted EPS fell to $0.81 from $1.12, while full year net income rose to $116.6 million and diluted EPS rose to $6.51 from $6.26, even though full year net sales declined to $1.84 billion from $1.95 billion.

  • Q4 2024 net sales were $444.1 million, down from $467.1 million in Q4 2023; Q4 net income was $14.2 million, or $0.81 per diluted share, versus $20.2 million, or $1.12, a year earlier
  • Q4 adjusted EBITDA was $64.8 million, down about 16% from $77.0 million, driven by lower sales and operating margins
  • Full year 2024 net income was $116.6 million, or $6.51 per diluted share, compared with $112.7 million, or $6.26, in 2023; full year net sales were $1.84 billion versus $1.95 billion
  • The company expects run-rate cost savings of at least $20 million in 2025 and said it expects revenue, adjusted EBITDA and earnings growth in 2025, but did not provide formal GAAP guidance
Read the filing on SEC.gov ↗
JBTMJBT MAREL Corp Feb 24, 4:29 PM ET

JBT Marel reports record Q4 orders; 2025 guidance projects loss from continuing operations

Mixed guidance Written later 2.02

JBT Marel reported fourth quarter and full year 2024 results for JBT standalone, with fourth quarter loss from continuing operations of $7 million and full year income from continuing operations of $85 million, down $45 million, reflecting M&A costs and a pension settlement expense. The company also provided 2025 guidance projecting a loss from continuing operations of $70 million to $35 million, with adjusted EPS of $5.50 to $6.10, and raised its cost synergy target to $150 million.

  • Q4 2024 JBT standalone: record quarterly orders of $523 million; loss from continuing operations of $7 million versus income of $53 million a year earlier
  • Full year 2024 JBT standalone: revenue of $1,716 million, up 3 percent; adjusted EBITDA of $295 million, up 8 percent
  • 2025 guidance: revenue of $3,575 million to $3,650 million; loss from continuing operations of $70 million to $35 million; adjusted EPS of $5.50 to $6.10
  • Cost synergy expectation raised from $125 million to $150 million within three years after the January 2, 2025 combination with Marel
Read the filing on SEC.gov ↗
ADUSAddus HomeCare Corp Feb 24, 4:27 PM ET

Addus HomeCare Q4 revenue rises 7.5% to $297.1 million; diluted EPS falls to $1.07

Mixed earnings Written later 2.027.01

Addus HomeCare reported fourth-quarter 2024 net service revenues of $297.1 million, up 7.5%, while GAAP net income of $19.5 million was roughly flat and diluted EPS fell to $1.07 from $1.20. For the full year, revenue rose 9.1% to $1.15 billion and net income rose to $73.6 million from $62.5 million, though the company's adjusted measures are non-GAAP and it reported no new guidance.

  • Q4 2024 net service revenues were $297.1 million, up from $276.4 million; adjusted EBITDA rose 10.3% to $37.8 million.
  • Q4 diluted EPS was $1.07 versus $1.20 a year earlier; adjusted diluted EPS was $1.38 versus $1.32.
  • Full-year 2024 net income was $73.6 million, or $4.23 per diluted share, compared with $62.5 million, or $3.83, in 2023.
  • Cash and equivalents were $98.9 million at December 31, 2024; the Gentiva personal care acquisition closed December 2, 2024.
Read the filing on SEC.gov ↗
LTCLTC PROPERTIES INC Feb 24, 4:24 PM ET

LTC Properties Q4 revenue rises to $52.6 million, but diluted EPS falls to $0.39

Mixed earnings Written later 2.02

LTC Properties reported fourth-quarter 2024 results with total revenues of $52.6 million, up from $50.2 million a year earlier. Net income available to common stockholders fell to $17.9 million from $28.1 million, and diluted EPS dropped to $0.39 from $0.67, while diluted NAREIT FFO per share rose to $0.72 from $0.57.

  • Total revenues were $52.6 million versus $50.2 million, including a one-time additional straight-line rental income of $3.2 million.
  • Diluted EPS was $0.39 versus $0.67; net income available to common stockholders was $17.9 million versus $28.1 million.
  • Diluted FFO per share, excluding non-recurring items, was $0.65 versus $0.66; the company cited a $7.0 million impairment loss in the quarter.
  • The company said initial RIDEA transactions are expected in the second quarter, and it will hold a conference call on February 25, 2025.
Read the filing on SEC.gov ↗
BRK-BBERKSHIRE HATHAWAY INC Feb 24, 4:15 PM ET

Berkshire Hathaway Q4 net earnings fell to $19.7 billion, operating earnings rose

Mixed earnings Written later 2.02

Berkshire Hathaway reported fourth-quarter 2024 net earnings of $19.7 billion, down from $37.6 billion a year earlier, mainly because investment gains fell to $5.2 billion from $29.1 billion. Operating earnings, which exclude investment gains and losses, rose to $14.5 billion from $8.5 billion, and full-year 2024 net earnings were $89.0 billion versus $96.2 billion in 2023.

  • Q4 2024 net earnings attributable to Berkshire shareholders were $19.7 billion, versus $37.6 billion in Q4 2023.
  • Q4 2024 operating earnings were $14.5 billion, versus $8.5 billion in Q4 2023; full-year operating earnings were $47.4 billion, versus $37.4 billion.
  • Q4 2024 net earnings per Class B share were $9.13, versus $17.36 a year earlier; full-year 2024 was $41.27, versus $44.27.
  • Berkshire used approximately $2.9 billion to repurchase its shares in 2024; insurance float was approximately $171 billion at December 31, 2024.
Read the filing on SEC.gov ↗

Apple Hospitality REIT Q4 net income rises 44% to $29.8 million

Mixed earnings Written later 2.02

Apple Hospitality REIT reported fourth-quarter and full-year 2024 results on February 24, 2025. Net income rose to $29.8 million for the quarter and $214.1 million for the year, while Comparable Hotels RevPAR grew 2.7% in the fourth quarter and 1.4% for the full year. The company's 2025 net income guidance of $173 million to $202 million is below its 2024 full-year net income of $214.1 million, so shareholders face mixed signals.

  • Q4 2024 net income was $29.8 million, up 43.6% from $20.8 million in Q4 2023.
  • Full-year 2024 net income per share was $0.89, up from $0.77 in 2023.
  • 2025 guidance projects net income of $173 million to $202 million and Comparable Hotels RevPAR change of 1.0% to 3.0%.
  • Q4 2024 Adjusted EBITDAre was $96.6 million, up 6.7%, and Comparable Hotels Adjusted Hotel EBITDA margin fell 40 basis points to 32.9%.
Read the filing on SEC.gov ↗
VCYTVERACYTE, INC. Feb 24, 4:11 PM ET

Veracyte Q4 revenue rises 21% to $118.6 million; French unit may enter bankruptcy

Mixed earnings Written later 2.02

Veracyte reported fourth-quarter 2024 revenue up 21% to $118.6 million and full-year 2024 net income of $24.1 million, compared with a net loss in 2023. The company is considering ending funding for its French subsidiary, Veracyte SAS, which could lead to bankruptcy proceedings after a works council consultation unless a buyer is found, and it is not providing total company revenue guidance for 2025.

  • Q4 2024 total revenue $118.6 million, up 21%; testing revenue $112.2 million, up 24%
  • Q4 2024 net income $5.1 million, diluted EPS $0.06; full-year 2024 net income $24.1 million, diluted EPS $0.31
  • 2025 testing revenue guidance $470 million to $480 million; no total revenue guidance due to Marseille, France uncertainty
  • Veracyte SAS may begin bankruptcy proceedings after works council consultation if no funding or buyer is identified
Read the filing on SEC.gov ↗
AORTARTIVION, INC. Feb 24, 4:08 PM ET

Artivion Q4 revenue up 4% to $97.3 million; net loss grows to $16.5 million

Mixed earnings Written later 2.02

Artivion reported fourth quarter 2024 revenue of $97.3 million, up 4% on a GAAP basis, and a net loss of $16.5 million, or $(0.39) per share, compared with a net loss of $4.0 million, or $(0.10) per share, a year earlier. For full year 2024, revenue rose 10% to $388.5 million and the net loss narrowed to $13.4 million. The company expects 2025 revenue of $420 million to $435 million and adjusted EBITDA of $84 million to $91 million, and said a late November 2024 cybersecurity incident negatively affected fourth quarter revenue.

  • Q4 2024 revenue $97.3 million, up 4% GAAP and 3% constant currency versus Q4 2023
  • Q4 2024 net loss $(16.5) million, or $(0.39) per diluted share, versus $(4.0) million, or $(0.10), in Q4 2023
  • Full year 2024 revenue $388.5 million, up 10%; adjusted EBITDA $71.3 million, up 32%
  • 2025 outlook: revenue $420 million to $435 million; adjusted EBITDA $84 million to $91 million
Read the filing on SEC.gov ↗
OREALTY INCOME CORP Feb 24, 4:07 PM ET

Realty Income Q4 AFFO per share rises 4.0% to $1.05; net income per share falls to $0.23

Mixed earnings Written later 2.027.01

Realty Income reported fourth-quarter 2024 results on February 24, 2025. Total revenue rose to $1.34 billion from $1.08 billion a year earlier, and AFFO per share increased 4.0% to $1.05, but net income available to common stockholders fell to $199.6 million, or $0.23 per share, from $218.4 million, or $0.30 per share, after $143.0 million of impairment provisions. The board also authorized a share repurchase program of up to $2.0 billion, and the company gave 2025 AFFO per share guidance of $4.22 to $4.28.

  • Q4 2024 net income per share was $0.23, down from $0.30 in Q4 2023; provisions for impairment were $143.0 million in the quarter
  • Q4 2024 AFFO per share rose 4.0% to $1.05; full-year 2024 AFFO per share rose 4.8% to $4.19
  • In February 2025, the board authorized a repurchase program of up to $2.0 billion in common stock, expiring January 2028
  • 2025 guidance: net income per share $1.52 to $1.58 and AFFO per share $4.22 to $4.28
Read the filing on SEC.gov ↗
EQHEquitable Holdings, Inc. Feb 24, 6:23 AM ET

Equitable Holdings to reinsure 75% of individual life block with RGA for over $2 billion

Mixed restructuring Written later 1.017.01

Equitable Holdings subsidiaries agreed on February 23, 2025 to cede a 75% quota share of their in-force individual life insurance block to RGA Reinsurance Company. The company expects over $2 billion of value from the deal, including a ceding commission and capital release, and plans to redeploy that capital into share repurchases and a larger stake in AllianceBernstein, but it also estimates a GAAP net loss at closing. The deal is expected to close in mid-2025, subject to regulatory approvals.

  • Agreement dated February 23, 2025 covers a 75% quota share of the in-force individual life insurance block with RGA Reinsurance Company
  • Company expects over $2 billion of value, including a positive ceding commission and release of capital
  • Company estimates a GAAP net loss at close and a reduction in book value excluding accumulated other comprehensive income
  • Planned uses of capital include a tender offer for up to $1.8 billion of AllianceBernstein Holdings units and $500 million of incremental share repurchases after closing; closing expected mid-2025
Read the filing on SEC.gov ↗
OCOwens Corning Feb 24, 6:02 AM ET

Owens Corning posts Q4 loss of $258 million on $483 million impairment; sales rise 13%

Mixed earnings Written later 2.02

Owens Corning reported a fourth-quarter 2024 net loss attributable to the company of $258 million, or $2.97 per diluted share, compared with net earnings of $131 million a year earlier. The loss reflects a $483 million impairment tied to its strategic review and a $91 million loss on sale of a business, while full-year net sales rose 13% to $11.0 billion. Full-year GAAP diluted EPS fell 44% to $7.37, though adjusted diluted EPS rose 10% to $15.91.

  • Q4 2024 net sales were $2.84 billion, up 23% from $2.30 billion; Q4 net loss attributable to the company was $258 million versus $131 million profit in Q4 2023.
  • Full-year 2024 net sales were $11.0 billion, up 13%; net earnings attributable to the company were $647 million, down 46%.
  • Full-year adjusted diluted EPS was $15.91, up 10%; GAAP diluted EPS was $7.37, down 44%.
  • The company expects Q1 2025 revenue from continuing operations to grow in the mid-20 percent range; the glass reinforcements sale is expected to close in 2025.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.